Kevin S. Boyle Sr. Alaunos Therapeutics, Inc. (TCRT) insider trading activity

TCRT Quotes by TradingView

Kevin S. Boyle Sr. is Chief Executive Officer of Alaunos Therapeutics, Inc.. Currently has a direct ownership of 798,236 shares of TCRT, which is worth approximately $1.56 Million. The most recent transaction as insider was on Sep 01, 2023, when has been sold 68,014 shares (Common Stock) at a price of $0.14 per share, resulting in proceeds of $9,521. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 798K
0% 3M change
0% 12M change
Total Value Held $1.56 Million

Kevin S. Boyle Sr. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 01 2023
SELL
Open market or private sale
$9,521 $0.14 p/Share
68,014 Reduced 7.85%
798,236 Common Stock
Aug 30 2022
SELL
Payment of exercise price or tax liability
$45,188 $2.41 p/Share
18,750 Reduced 2.12%
866,250 Common Stock
Nov 17 2021
BUY
Open market or private purchase
$12,762 $1.4 p/Share
9,116 Added 1.02%
885,000 Common Stock
Nov 16 2021
BUY
Open market or private purchase
$1,238 $1.4 p/Share
884 Added 0.1%
875,884 Common Stock
Aug 30 2021
BUY
Grant, award, or other acquisition
-
875,000 Added 50.0%
875,000 Common Stock
KSB

Kevin S. Boyle Sr.

Chief Executive Officer
Houston, TX

Track Institutional and Insider Activities on TCRT

Follow Alaunos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRT shares.

Notify only if

Insider Trading

Get notified when an Alaunos Therapeutics, Inc. insider buys or sells TCRT shares.

Notify only if

News

Receive news related to Alaunos Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TCRT